Isoalloxazine
| Names | |
|---|---|
| IUPAC name 1H-benzo[g]pteridine-2,4-dione | |
| Other names 1,2,3,4-Tetrahydrobenzopteridine-2,4-dione; Benzo(g)pteridine-2,4(1H,3H)-dione | |
| Identifiers | |
| 3D model (JSmol) | |
| 85819 | |
| ChEBI | |
| ChEMBL | |
| ChemSpider | |
| ECHA InfoCard | 100.007.014 | 
| EC Number | 
 | 
| PubChem CID | |
| UNII | |
| CompTox Dashboard (EPA) | |
| 
 | |
| 
 | |
| Properties | |
| C10H6N4O2 | |
| Molar mass | 214.184 g·mol−1 | 
| Appearance | Red solid | 
| Melting point | 200 °C (392 °F; 473 K) | 
| Except where otherwise noted, data are given for materials in their standard state (at 25 °C [77 °F], 100 kPa). Infobox references | |
Isoalloxazine is the structural foundation of flavins such as riboflavin (vitamin B2) and is a heterocyclic compound. It has a tricyclic structure which means it has three interconnected rings of atoms and is a tautomer of alloxazine. The structure is formed by primary-secondary aromatic o-diamines and they are a high-melting crystalline substance. The R-group is used to attach various flavin groups It has a similar structure to pteridines which has two interconnected rings. Isoalloxazine was first obtained in 1934 by Richard Kuhn an Austrian-German biochemist and lab mates.